ESI and CVS blocking Nesina on 2015 formulary

Discussion in 'Takeda' started by Anonymous, Nov 25, 2014 at 7:41 PM.

Tags: Add Tags
  1. Anonymous

    Anonymous Guest

    patient pays $4. Takeda gets more from negotiated contracts that insurers pick up part of the tab.
     

  2. Anonymous

    Anonymous Guest

    Sarcasm you stupid fuck.
     
  3. Anonymous

    Anonymous Guest

    im an idiot but if its ndc blocked than the insurance company says we will rebate Takeda back. Obviously since im dumb they reimburse us back 100%. Same as all those dumb investors for Contrave they have concerns over profit margin/revenue. You should mention to them they don't understand how insurance rebates for things that are ndc blocked/not covered. That they are rebates that Takeda does not disclose to investors or creditors. Somehow this idiot thinks that might be illegal.

    What is the rebate from insurance for these 2 drugs at low to very low copays especially since the real cost is probably over $250 for a months supply? As an investor I should know.
     
  4. Anonymous

    Anonymous Guest

    Compounding pharmacies are looking into making Contrave ish drug. But we don't have to worry because that could never happen with 2 generics.
     
  5. Anonymous

    Anonymous Guest

    Yes you are an idiot. If the drug is NDC blocked, the patient pays 100% of the cost at the pharmacy. Any discount is paid for by Takeda. The insurance company does not pay. The only exception is if the drug is deemed "medically necessary" which means the physician has to provide documentation why the patient has to take this drug versus a comparable drug that is on formulary. If approved, the patient pays the copay of the comparable drug at retail (pharmacy) and the drug is not rebated by Takeda to the plan because it is not on formulary.
    Nothing illegal about it. Hopefully you only "invest" your own money and don't offer your expertise to others.